Daiichi Sankyo promoted Hiroyuki Okuzawa to CEO, and he will take over from Sunao Manabe on April 1.
Okuzawa is currently …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
In people with heart disease and comorbid anxiety or depression, mental health treatment showed strong links to better clinical outcomes in an observational analysis of
Pfizer’s not-so-good year continues. The New York pharma giant’s shares $PFE slid 7% before Wednesday’s opening bell after Pfizer said it plans to cut another
Untreated vision loss and high LDL cholesterol have been added as two new potentially modifiable risk factors for dementia in a report released Wednesday by